Stay updated on DTX301 Clinical Trial in Late-Onset OTC Deficiency
Sign up to get notified when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.
Latest updates to the DTX301 Clinical Trial in Late-Onset OTC Deficiency page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNo significant changes to the study details were detected; the page content remains focused on safety and dose-finding of DTX301 with the same eligibility criteria, study arms, and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedTerminology updated from “Urea cycle disorder” to “Disorder of the urea cycle metabolism” and version bumped from v3.0.2 to v3.2.0; core topic remains but with more precise naming and a new release version.SummaryDifference0.3%
- Check41 days agoChange DetectedOverall, the page updates its terminology from “Urea cycle disorder” to “Disorder of the urea cycle metabolism” and advances the revision to v3.1.0, signaling a broader description and a new version.SummaryDifference0.3%
- Check55 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the Back to Top element.SummaryDifference0.2%
- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed medical terms related to ornithine carbamoyltransferase deficiency and urea cycle disorders. The revision number has also been updated to v3.0.0.SummaryDifference4%
Stay in the know with updates to DTX301 Clinical Trial in Late-Onset OTC Deficiency
Enter your email address, and we'll notify you when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.